共查询到20条相似文献,搜索用时 31 毫秒
1.
Lung carcinoma is one of the leading causes of death worldwide. It is a non-immunogenic cancer, resistant to immune surveillance.
Toll-like receptors (TLRs) connect the innate to the adaptive immune system. Given that cancerous cells evade the immune system,
the activation of TLRs could represent a potential target for cancer therapy. The induction of Th1-like and cytotoxic immunity
by TLR signalling could lead to tumour cell death, resulting in tumour regression or arrest. However, basic research and clinical
trials revealed that the activation of specific TLRs, such as TLR2, TLR4 and TLR9, do not have any anti-tumour activity in
lung carcinoma. Increasing evidence suggests that TLRs are important regulators of tumour biology; however, little is known
about their function in lung cancer. Thus, in order to develop new therapeutic approaches, further studies are needed to understand
the connection between TLRs and lung cancer progression. This review focuses on the potential mechanisms by which TLR ligands
can facilitate or not lung cancer and lung metastases establishment/progression. 相似文献
2.
Toll-like receptor expression in normal ovary and ovarian tumors 总被引:1,自引:0,他引:1
Mingfu Zhou Molly M. McFarland-Mancini Holly M. Funk Nader Husseinzadeh Taofic Mounajjed Angela F. Drew 《Cancer immunology, immunotherapy : CII》2009,58(9):1375-1385
Recent studies have implicated inflammation in the initiation and progression of ovarian cancer, though the mechanisms underlying
this effect are still not clear. Toll-like receptors (TLRs) allow immune cells to recognize pathogens and to trigger inflammatory
responses. Tumor cell expression of TLRs can promote inflammation and cell survival in the tumor microenvironment. Here we
sought to characterize the expression of TLRs in normal human ovaries, benign and malignant ovarian tumors from patients,
and in established ovarian tumor cell lines. We report that TLR2, TLR3, TLR4, and TLR5 are strongly expressed on the surface
epithelium of normal ovaries. In contrast to previous studies of uterus and endocervix, we found no cyclic variation in TLR
expression occurred in murine ovaries. TLR2, TLR3, TLR4, and TLR5 are expressed in benign conditions, epithelial tumors, and
in ovarian cancer cell lines. Variable expression of TLR6 and TLR8 was seen in benign and malignant epithelium of some patients,
while expression of TLR1, TLR7, and TLR9 was weak. Normal and malignant ovarian stroma were negative for TLR expression. Vascular
endothelial cells, macrophages, and occasional fibroblasts in tumors were positive. Functional activity for TLRs was demonstrated
by stimulation of cell lines with specific ligands and subsequent activation and translocation of NFκB and release of the
proinflammatory cytokines interleukin-6 and CCL-2. These studies demonstrate expression of multiple TLRs in the epithelium
of normal ovaries and in ovarian tumor cells, and may indicate a mechanism by which epithelial tumors manipulate inflammatory
pathways to facilitate tumor progression. 相似文献
3.
Wang L Liu Q Sun Q Zhang C Chen T Cao X 《Biochemical and biophysical research communications》2008,366(3):852-856
Toll-like receptors (TLRs) are involved in the production of inflammatory mediators upon specific ligands stimuli. Chemokines are important inflammatory mediators capable of chemoattracting diverse immune cells. In addition to normal immune cells, the expression of TLRs and chemokines has been detected in various tumor cells. However, the roles of TLRs and chemokines expressed by tumor cells in the processes of tumor progression and immune escape have not been fully elucidated. Here we report that TLR4 ligation by lipopolysaccharide (LPS) significantly promotes CT-26 colon cancer cells to produce chemokine CCL20 via activation of TLR4 signaling pathways. We find that LPS treatment of CT-26 cells can significantly increase the chemoattraction of immature dendritic cells (DC) by the autocrine CCL20. Our studies suggest that TLR4 expressed by tumor cells may be involved in the induction of chemokines like CCL20, providing a potential linkage between chronic inflammation and tumor immune escape. 相似文献
4.
Treg细胞具有维持自身免疫耐受,调节免疫应答的作用。Toll样受体(Toll-like receptors,TLRs)家族可识别病原相关分子模式或内源性配体,启动固有和适应性免疫应答。Treg细胞选择性表达某些TLRs,TLRs活化可能直接增强或降低Treg的免疫抑制功能,这种调节可以影响对感染和肿瘤的免疫监视、移植免疫排斥和自身免疫病发生的进程。因此,了解两者的关系对发现新的治疗靶点和对策有重要的作用。简要综述TLRs对Treg细胞抑制功能直接调节作用的研究进展。 相似文献
5.
Li Yu Liantang Wang Mengzhen Li Juemin Zhong Zhuo Wang Shangwu Chen 《Cancer immunology, immunotherapy : CII》2010,59(7):1021-1028
Chronic infection and inflammation are among the most important factors contributing to cancer development and growth. Toll-like
receptors (TLRs) are important families of pattern recognition receptors, which recognize conserved components of microbes
and trigger the immune response against invading microorganisms. TLR4 is the signaling receptor for lipopolysaccharide (LPS),
the endotoxic component of Gram-negative bacteria. Recent studies demonstrate that TLRs are expressed in some tumor cells,
and that the expression of TLRs in these cells is associated with tumorigenesis. Cervical intraepithelial neoplasia (CIN)
is a key stage in the development of cervical cancer and human papillomavirus (HPV) infection is an essential factor in cervical
carcinogenesis. As the cervix is in constant contact with bacteria, especially Gram-negative bacteria, we hypothesize that
TLR4-mediated bacterial stimulation may be involved in the tumorigenesis of cervical cancer. In the present study, the expression
and distribution of TLR4 in CIN and cervical squamous carcinoma were investigated by immunohistochemistry. To our surprise,
we observed a decrease in the expression of TLR4 during the progression of cervical neoplasia and this down-regulation of
TLR4 appeared to be associated with the expression of
\textP 1 6\textINK4A , {\text{P}}^{{ 1 6^{\text{INK4A}} }} , which is a crucial marker of HPV integration into host cells. These data offer further insight regarding the association
of HPV infection and TLR signaling during the carcinogenesis of cervical cancer. 相似文献
6.
Toll-like receptors (TLRs) are a group of transmembrane receptors which play a key role in both innate and adaptive immune responses. The specific exogenous ligands of TLRs are pathogen-associated molecular patterns such as peptidoglycan, flagellin, teichoic acid, CPG-containing DNA, and others. Stimulation of TLRs induces synthesis and secretion of cytokines, upregulation of co-stimulatory molecules and functional maturation of antigen-presenting cells and leads to the development of both protective and damaging adaptive immune reactions. TLRs are also able to interact with a number of endogenic ligands such as fibronectine, heat shock proteins and extracellular matrix components. Thus, TLRs are involved in the development of many pathological states including sepsis and aseptic inflammation, allergy and autoimmune diseases, cancer. In the recent years several biotechnology and pharmaceutical companies developed new drugs that are either agonists of TLRs to enhance immune responses against tumours and infecious agents or to correct inadequate immune reactions or antagonists designed to reduce the inflammation caused by infection or autoimmune diseases. The paper presents current data concerning TLRs biology, the contribution of TLRs to pathogenesis of human diseases and completed, ongoing and planned clinical trials with immunotherapeutic drugs based on TLR agonists and antagonists. 相似文献
7.
《Cellular signalling》2014,26(11):2350-2357
Breast cancer is one of the leading causes of mortality in the females. Intensive efforts have been made to understand the molecular mechanisms of pathogenesis of breast cancer. The physiological conditions that lead to tumorigenesis including breast cancer are not well understood. Toll like receptors (TLRs) are essential components of innate immune system that protect the host against bacterial and viral infection. The emerging evidences suggest that TLRs are activated through pathogen associated molecular patterns (PAMPs) as well as endogenous molecules, which lead to the activation of inflammatory pathways. This leads to increased levels of several pro-inflammatory cytokines and chemokines mounting inflammation. Several evidences support the view that chronic inflammation can lead to cancerous condition. Inflammation aids in tumor progression and metastasis. Association of inflammation with breast cancer is emerging. TLR mediated activation of NF-κB and IRF is an essential link connecting inflammation to cancer. The recent reports provide several evidences, which suggest the important role of TLRs in breast cancer pathogenesis and recurrence. The current review focuses on emerging studies suggesting the strong linkages of TLR mediated regulation of inflammation during breast cancer and its metastasis emphasizing the initiation of the systematic study. 相似文献
8.
Motahare Boozari Alexandra E. Butler Amirhossein Sahebkar 《Journal of cellular physiology》2019,234(8):12471-12482
Toll-like receptors (TLRs) have a pivotal role in the activation of innate immune response and inflammation. TLRs can be divided into two subgroups including extracellular TLRs that recognize microbial membrane components (TLR1, 2, 4, 5, 6, and 10), and intracellular TLRs that recognize microbial nucleic acids (TLR3, 7, 8, and 9). Curcumin is a dietary polyphenol from Curcuma longa L. that is reputed to have diverse biological and pharmacological effects. Extensive research has defined the molecular mechanisms through which curcumin mediates its therapeutic effects. One newly defined and important target of curcumin is the TLR, where it exerts an inhibitory effect. In the current study, we focus upon the TLR antagonistic effect of curcumin and curcumin's therapeutic effect as mediated via TLR inhibition. The available evidence indicates that curcumin inhibits the extracellular TLR 2 and 4 and intracellular TLR9 and thereby exerts a therapeutic effect in diseases such as cancer, inflammation, infection, autoimmune, and ischemic disease. Curcumin effectively modulates the TLR response and thereby exerts its potent therapeutic effects. 相似文献
9.
10.
Guido Gambara Paola De Cesaris Cosimo De Nunzio Elio Ziparo Andrea Tubaro Antonio Filippini Anna Riccioli 《Journal of cellular and molecular medicine》2013,17(6):713-722
Toll‐Like receptors (TLRs) are a family of evolutionary conserved transmembrane proteins that recognize highly conserved molecules in pathogens. TLR‐expressing cells represent the first line of defence sensing pathogen invasion, triggering innate immune responses and subsequently priming antigen‐specific adaptive immunity. In vitro and in vivo studies on experimental cancer models have shown both anti‐ and pro‐tumoural activity of different TLRs in prostate cancer, indicating these receptors as potential targets for cancer therapy. In this review, we highlight the intriguing duplicity of TLR stimulation by pathogens: their protective role in cases of acute infections, and conversely their negative role in favouring hyperplasia and/or cancer onset, in cases of chronic infections. This review focuses on the role of TLRs in the pathophysiology of prostate infection and cancer by exploring the biological bases of the strict relation between TLRs and prostate cancer. In particular, we highlight the debated question of how reliable mutations or deregulated expression of TLRs are as novel diagnostic or prognostic tools for prostate cancer. So far, the anticancer activity of numerous TLR ligands has been evaluated in clinical trials only in organs other than the prostate. Here we review recent clinical trials based on the most promising TLR agonists in oncology, envisaging a potential application also in prostate cancer therapy. 相似文献
11.
Eda K. Holl Kara L. Shumansky George Pitoc Elizabeth Ramsburg Bruce A. Sullenger 《PloS one》2013,8(7)
Toll-like receptor (TLR) family members, 3, 7 and 9 are key components in initiation and progression of autoimmune disorders such as systemic lupus erythematosus (SLE). These TLRs are often referred to as nucleic acid-sensing TLRs based on their ability to recognize DNAs or RNAs produced by pathogens or damaged cells. During autoimmune disease progression these receptors recognize self nucleic acids as well as self nucleic acid-containing complexes and contribute to inflammatory cytokine production and subsequent enhancement of serum autoantibody levels. We have recently discovered that nucleic-acid scavenging polymers (NASPs) can neutralize the proinflammatory effects of nucleic acids. Here, we begin to explore what effects such NASPs have on normal immune function. We show that such NASPs can inhibit TLR activation without affecting nucleic acid-independent T cell activation. Moreover, we observe that stimulation of immune cells by encapsulated nucleic acids, such as those found in viral particles, is unaffected by NASPs. Thus NASPs only limit the activation of the immune system by accessible extra-cellular nucleic acid and do not engender non-specific immune suppression. These important findings suggest that NASPs represent a new approach toward anti-inflammatory drug development as these agents can potentially be utilized to block overt autoimmune disorders and inflammation while allowing normal immune responses to occur. 相似文献
12.
The innate immune receptors, such as Toll-like receptors (TLRs), are intimately involved in the early sensing of invading
microorganisms or their structural components. Engagement of TLRs with their ligands results in activation of several downstream
intracellular pathways leading to activation of innate and adaptive immune system cells. It was initially thought that TLRs
are primarily expressed by antigen-presenting cells (APCs), such as macrophages and dendritic cells, and that interactions
between microbial ligands and TLRs in these cells will indirectly result in activation of cells of the adaptive immune system,
especially T cells. However, it has now become evident that TLRs are also expressed by various T cell subsets, such as conventional
αβT cells, regulatory T cells, and γδT cells as well as natural killer T cells. Importantly, it appears that at least in some
of these T cell subsets, TLRs are functionally active, because stimulation of these cells with TLR agonists in the absence
of APCs results in exertion of effector or regulatory functions of T cells. The present review attempts to summarize the recent
findings related to TLR expression in different T cell subsets and the direct role of TLRs in the induction and regulation
of T cell responses, including those responses that occur at mucosal surfaces. In addition, the potential use of TLR agonists
for steering T cell responses as a prophylactic or therapeutic strategy in the context of infectious, allergic or autoimmune
diseases is explored. 相似文献
13.
《Autophagy》2013,9(2):257-268
Autophagy contributes to the pathogenesis of cancer, whereas toll-like receptors (TLRs) also play an important role in cancer development and immune escape. However, little is known about the potential interaction between TLR signaling and autophagy in cancer cells. Here we show that autophagy induced by TLR4 or TLR3 activation enhances various cytokine productions through promoting TRAF6 (TNF receptor-associated factor 6, E3 ubiquitin protein ligase) ubiquitination and thus facilitates migration and invasion of lung cancer cells. Stimulation of TLR4 and TLR3 with lipopolysaccharide (LPS) and polyinosinic-polycytidylic acid [poly(I:C)] respectively triggered autophagy in lung cancer cells. This was mediated by the adaptor protein, toll-like receptor adaptor molecule 1 (TICAM1/TRIF), and was required for TLR4- and TLR3-induced increases in the production of IL6, CCL2/MCP-1 [chemokine (C-C motif) ligand 2], CCL20/MIP-3α [chemokine (C-C motif) ligand 20], VEGFA (vascular endothelial growth factor A), and MMP2 [matrix metallopeptidase 2 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV collagenase)]. These cytokines appeared to be necessary for enhanced migration and invasion of lung cancer cells upon TLR activation. Remarkably, inhibition of autophagy by chemical or genetic approaches blocked TLR4- or TLR3-induced Lys63 (K63)-linked ubiquitination of TRAF6 that was essential for activation of MAPK and NFKB (nuclear factor of kappa light polypeptide gene enhancer in B-cells) pathways, both of which were involved in the increased production of the cytokines. Collectively, these results identify induction of autophagy by TLR4 and TLR3 as an important mechanism that drives lung cancer progression, and indicate that inhibition of autophagy may be a useful strategy in the treatment of lung cancer. 相似文献
14.
Chemotherapy and immunotherapy can be either synergistic or antagonistic modalities in the treatment of cancer. Cytotoxic chemotherapy not only affects the tumor but also targets dividing lymphocytes, the very cells that are required to develop an immune response. For this reason, chemo- and immunotherapy have been seen as antagonistic. However, cell death can be immunogenic and the way in which chemotherapeutic drug kills a tumor cell is likely to be an important determinant of how that dying cell interacts with the immune system and whether the interaction will lead to an immune response. When a cell dies as the result of infection, the immune system responds rapidly and the system of Toll-like receptors (TLR) plays a key role in this process. In this review, we will briefly summarize the intracellular signaling pathways that link TLR ligation with immune activation and we will address the questions where and how TLRs recognize their targets. 相似文献
15.
Toll-like receptors (TLRs) have been described as major components of the innate immune system, recognizing the conserved
molecular structures found in the large groups of pathogens called pathogen-associated molecular patterns (PAMPs). TLR expression
is ubiquitous, from epithelial to immunocompetent cells. TLR ligation triggers several adapter proteins and downstream kinases,
leading to the induction of key pro-inflammatory mediators but also anti-inflammatory and anti-tumor cytokines. The result
of this activation goes beyond innate immunity to shape the adaptive responses against pathogens and tumor cells, and maintains
host homeostasis via cell debris utilization. TLRs have already become potent targets in infectious disease treatment and
vaccine therapy and in neoplastic disease treatment, due to their ability to enhance antigen presentation. However, some studies
show the dual effect of TLR stimulation on malignant cells: they can be proapoptotic or promote survival under different conditions.
It is therefore crucial to design further studies assessing the biology of these receptors in normal and transformed cells.
The established role of TLRs in human disease therapy is based on TLR7 and TLR4 agonists, respectively for the novel treatment
of some types of skin cancer and for the anti-hepatitis B virus vaccine. Some clinical trials involving TLR agonists as potent
enhancers of the anti-tumor response in solid tumors have begun. 相似文献
16.
Chronic inflammation promotes tumor development and progression, and Toll-like receptors (TLRs) may play an important role in this process. In this study, we found that human prostate epithelial PC3 cells constitutively express TLR4 in mRNA and protein level. lipopolysaccharide (LPS) promotes the expression and secretion of immunosuppressive cytokine TGFβ1 and proangiogenic factor VEGF in human prostate epithelial PC3 cells. We further elucidated that functionally activation of TLR4 is essential for the increased VEGF and TGFβ1 mRNA expression in the cells. In addition, after LPS stimulation, the increased expression of NF-KB p65 protein was also detected in human PC3 cells. Our results demonstrate that TLR4 expressed on human PC3 cells is functionally active, and may play important roles in promoting prostate cancer immune escape, survival, progression, and metastasis by inducing immunosuppressive and proangiogenic cytokines. 相似文献
17.
18.
Zhenzhen Zhan Xuefeng Xie Hao Cao Xiaohui Zhou Xu Dong Zhang Huimin Fan Zhongmin Liu 《Autophagy》2014,10(2):257-268
Autophagy contributes to the pathogenesis of cancer, whereas toll-like receptors (TLRs) also play an important role in cancer development and immune escape. However, little is known about the potential interaction between TLR signaling and autophagy in cancer cells. Here we show that autophagy induced by TLR4 or TLR3 activation enhances various cytokine productions through promoting TRAF6 (TNF receptor-associated factor 6, E3 ubiquitin protein ligase) ubiquitination and thus facilitates migration and invasion of lung cancer cells. Stimulation of TLR4 and TLR3 with lipopolysaccharide (LPS) and polyinosinic-polycytidylic acid [poly(I:C)] respectively triggered autophagy in lung cancer cells. This was mediated by the adaptor protein, toll-like receptor adaptor molecule 1 (TICAM1/TRIF), and was required for TLR4- and TLR3-induced increases in the production of IL6, CCL2/MCP-1 [chemokine (C-C motif) ligand 2], CCL20/MIP-3α [chemokine (C-C motif) ligand 20], VEGFA (vascular endothelial growth factor A), and MMP2 [matrix metallopeptidase 2 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV collagenase)]. These cytokines appeared to be necessary for enhanced migration and invasion of lung cancer cells upon TLR activation. Remarkably, inhibition of autophagy by chemical or genetic approaches blocked TLR4- or TLR3-induced Lys63 (K63)-linked ubiquitination of TRAF6 that was essential for activation of MAPK and NFKB (nuclear factor of kappa light polypeptide gene enhancer in B-cells) pathways, both of which were involved in the increased production of the cytokines. Collectively, these results identify induction of autophagy by TLR4 and TLR3 as an important mechanism that drives lung cancer progression, and indicate that inhibition of autophagy may be a useful strategy in the treatment of lung cancer. 相似文献
19.
Toll-like receptors (TLRs), mainly expressing in human immune related cells and epithelial cells, play an essential role in the host defense against microbes by recognizing conserved bacterial molecules. Recently, the expression or up-regulation of TLRs has been detected in many tumor cell lines or tumors, especially epithelial derived cancers. Although the TLR profile varies on different tumor cells, the current evidences indicate that the expression of TLRs is functionally associated with tumor progression. TLR expression may promote malignant transformation of epithelial cells. Engagement of TLRs increases tumor growth and tumor immune escape, and induces apoptosis resistance and chemoresistance in some tumor cells. These findings demonstrate that TLR is a promising target for the development of anticancer drugs and make TLR agonists or antagonists the potential agents for tumor therapy. 相似文献
20.
Toll样受体(Toll-like receptors, TLRs)在先天免疫系统中广泛表达,可通过促进抗原提呈细胞(antigen presenting cells,APC)共刺激分子的表达从而间接导致T细胞活化。然而研究发现,TLR也可在T细胞中表达,并可在没有APC的情况下直接调节T细胞的代谢与功能。本文综述了TLR信号对不同T细胞亚群代谢和免疫功能的直接调控作用,为T细胞介导的癌症及自身免疫病等疾病的预防和治疗提供了新的思路。 相似文献